When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRK - ANI Pharma files U.S. application for competitor to Mallinckrodt's Acthar Gel
Merck & Company Inc.
ANI Pharmaceuticals (ANIP+13.1%) has filed a marketing application with the FDA seeking approval to reintroduce Purified Cortrophin Gel (repository corticotropin injection USP) (80 U/mL) into the U.S. market aimed at taking market share from Mallinckrodt's (MNK+0.6%) top seller Acthar Gel (repository corticotropin injection) 80 U/mL.
More news on: ANI Pharmaceuticals, Inc., Mallinckrodt plc, Merck & Co., Inc., Healthcare stocks news, Stocks on the move,